These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10363174)

  • 1. Detection and clinical significance of plasma glutathione-S-transferases in dogs with lymphoma.
    Hahn KA; Barnhill MA; Freeman KP; Shoieb AM
    In Vivo; 1999; 13(2):173-5. PubMed ID: 10363174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum alpha 1-acid glycoprotein concentrations before and after relapse in dogs with lymphoma treated with doxorubicin.
    Hahn KA; Freeman KP; Barnhill MA; Stephen EL
    J Am Vet Med Assoc; 1999 Apr; 214(7):1023-5. PubMed ID: 10200796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo-controlled study.
    Ogilvie GK; Fettman MJ; Mallinckrodt CH; Walton JA; Hansen RA; Davenport DJ; Gross KL; Richardson KL; Rogers Q; Hand MS
    Cancer; 2000 Apr; 88(8):1916-28. PubMed ID: 10760770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
    Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
    J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration of alpha 1-acid glycoprotein in dogs with malignant neoplasia.
    Ogilvie GK; Walters LM; Greeley SG; Henkel SE; Salman MD
    J Am Vet Med Assoc; 1993 Oct; 203(8):1144-6. PubMed ID: 8244860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV).
    Katahira T; Takayama T; Miyanishi K; Hayashi T; Ikeda T; Takahashi Y; Takimoto R; Matsunaga T; Kato J; Niitsu Y
    Clin Cancer Res; 2004 Dec; 10(23):7934-40. PubMed ID: 15585627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
    Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
    J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
    Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006).
    Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE
    J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of glutathione S-transferase-pi in human esophageal squamous cell carcinoma].
    Li Z; Zhang R; Luo X
    Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):39-42. PubMed ID: 11783067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional relationship of alpha-glutathione S-transferase and glutathione S-transferase activity in machine-preserved non-heart-beating donor kidneys.
    Van Kreel BK; Janssen MA; Kootstra G
    Transpl Int; 2002 Nov; 15(11):546-9. PubMed ID: 12461658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum C-reactive protein concentrations in dogs with multicentric lymphoma undergoing chemotherapy.
    Merlo A; Rezende BC; Franchini ML; Simões DM; Lucas SR
    J Am Vet Med Assoc; 2007 Feb; 230(4):522-6. PubMed ID: 17302548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between GSTP1 gene polymorphism and serum alpha-GST concentrations undergoing sevoflurane anaesthesia.
    Kaymak C; Karahalil B; Ozcan NN; Oztuna D
    Eur J Anaesthesiol; 2008 Mar; 25(3):193-9. PubMed ID: 17892615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma glutathione S-transferase pi 1-1 AND alpha 1-1 levels in patients with bladder cancer.
    Berendsen CL; Mulder TP; Peters WH
    J Urol; 2000 Dec; 164(6):2126-8. PubMed ID: 11061940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
    Huang J; Tan PH; Thiyagarajan J; Bay BH
    Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay.
    Von Euler HP; Rivera P; Aronsson AC; Bengtsson C; Hansson LO; Eriksson SK
    Int J Oncol; 2009 Feb; 34(2):505-10. PubMed ID: 19148486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chemotherapy and remission on carbohydrate metabolism in dogs with lymphoma.
    Ogilvie GK; Vail DM; Wheeler SL; Fettman MJ; Salman MD; Johnston SD; Hegstad RL
    Cancer; 1992 Jan; 69(1):233-8. PubMed ID: 1727668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effects of dietary n-3 fatty acid supplementation on the pharmacokinetics of doxorubicin in dogs with lymphoma.
    Selting KA; Ogilvie GK; Gustafson DL; Long ME; Lana SE; Walton JA; Hansen RA; Turner AS; Laible I; Fettman MJ
    Am J Vet Res; 2006 Jan; 67(1):145-51. PubMed ID: 16426224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.